PDF-Guided PCI vs. CABG

FAME 3 Trial FFR William F Fearon MD Associate Professor of Medicine Director Interventional Cardiology Stanford University Medical Center Background SYNTAX Trial One Year MACCE Results Ser. Susana G. Garcia MD. No Disclosure. Objectives. Review the current definition, risk factors, clinical impact and incidence of PMI. Describe the different clinical presentation of PMI and how this dictate the goal and approach to diagnosis and treatment of PMI. bypass grafting in treatment of unprotected left . main stenosis. Nordic–Baltic–British . left main . revascularisation study . (NOBLE. ). A . prospective, randomised, open-label. , non-inferiority trial. Sawan. , Bassam . Abou. Khalil.. Faculty of Medicine, University of . Balamand. , Beirut, Lebanon.. Daniel J. Rader.. Perelman School of Medicine, University of Pennsylvania, PA USA.. Very Severe Hypertriglyceridemia Prior to CABG: .  . In . the SYNTAX Trial (1800 patients with 3-vessel or left main CAD randomized to CABG or PCI (in a 1:1 ratio), rates of . MACCE at . 12 months were significantly higher in the PCI group (17.8%, vs. 12.4%, P = 0.002. bypass grafting in treatment of unprotected left . main stenosis. Nordic–Baltic–British . left main . revascularisation study . (NOBLE. ). A . prospective, randomised, open-label. , non-inferiority trial. Revascularization in Stable Ischemic Heart Disease. Bobby Mathew, MD. LSU Internal Medicine, HO-II. Definitions. Recommendations for revascularization in the setting of symptomatic, stable ischemic heart disease; does not include revascularization in the setting of acute MI. vascular disease renaldisease CRI is an independent risk factor hepatic insufficiency will change anestheticmanagementAllergiesMedications Look specifically for anti-anginal regimen - synergism betwe vs.. . c. oronary artery bypass for multi-vessel disease: a meta-analysis. . Nirav C Patel MD, Jonathan M Hemli MD, Karthik Seetharam MD, Annapoorna Uttara BS, Derek R Brinster MD,. . Luigi Pirelli MD, Chad . On behalf of the PRECOMBAT Investigators. Professor of Medicine, University of Ulsan College of Medicine, . Heart Institute, Asan Medical Center, Seoul, Korea . PRECOMBAT Trial. Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using . 9 th CathLab Course, Nice 2015 FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst , Belgium 9 th Coronary Physiology in the CathLab Course, Nice 2015 • Institutional resea SocietySurgeons(ANZSCTS)ZealandElsevierrights *CorrespondingauthorMonashCardiovascularResearchCentre,UniversityMonashHeart,Health,adam.brown@monash.edu BackgroundOff-pump coronary artery bypass grafti "",,~~~._-~~~~~~~~ fILE COpy SURGERY ASSURING QUALITY WHILE CONTROLLING MEDICARE COSTS OFFICE OF INSPECTOR GENERAL OFFICE OF ANALYSIS AND INSPECTIONS ':'3 ".......oz..­ I"'E ";t. s;.r". Au lesions. The hazard . was highest . with CABG in the first 30 . days with better outcomes with PCI; between . 30 days and . 5 . years, . outcomes were inferior . with PCI compared with . CABG. CABG. (n = 592). Kappetein. , Joseph F. . Sabik. , Patrick W. . Serruys. and the EXCEL investigators. EXCEL. Five-year Outcomes from a Randomized Trial of PCI vs. CABG in Patients with Left Main Coronary Artery Disease.